Lipoprotein(a) vascular accumulation in mice: In vivo analysis of the role of lysine binding sites using recombinant adenovirus

Journal of Clinical Investigation

Volumn 100, Issue 6, 1997, Pages 1493-1500

  Hughes, Steven D ^a   Lou, Xing Jian ^b   Ighani, Shahla ^a   Verstuyft, Judy ^a   Grainger, David J ^c   Lawn, Richard M ^b   Rubin, Edward M ^a  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Atherosclerosis, physiopathology; Gene transfer; Lipoprotein(a), analysis; Transgenic mice

Indexed keywords

APOLIPOPROTEIN A; FIBRIN; LIPOPROTEIN A;

ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; GENE TRANSFER; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; TRANSGENIC MOUSE;

EID: 1842326803     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119671     Document Type: Article

References (36)

1. 4057 of apolipoprotein(a) is essential for lipoprotein(a) assembly. Proc. Natl. Acad. Sci. USA 90:11643-11647.
2. Koschinsky, M.L., G.P. Cote, B. Gabel, and Y.Y. van der Hoek. 1993. Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoprotein B-100. J. Biol. Chem. 268:19819-19825.
3. Utermann, G. 1989. The mysteries of lipoprotein (a). Science (Wash. DC). 246:904-910.
4. Maher, V.M.G., and B.G. Brown. 1995. Lipoprotein(a) and coronary heart disease. Curr. Clin. Lipidol. 6:229-235.
5. Cushing, G.L., J. Gaubatz, M. Nava, B. Burdick, T. Bocan, J. Guynton, D. Weilbaecher, M. DeBakey, G. Lowrie, and J. Morrisett. 1989. Quantification and localization of apolipoprotein(a) and B in coronary artery bypass vein grafts resected at re-operation. Arteriosclerosis. 9:593-603.
6. Rath, M., A. Niendorf, T. Reblin, M. Dietel, H.-J. Krebber, and U. Beisiegel. 1989. Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis. 9:579-592.
7. Pepin, J.M., J.A. O'Neil, and H.F. Hoff. 1991. Quantification of apo(a) and apoB in human atherosclerotic lesions. J. Lipid Res. 32:317-327.
8. Nachman, R.L. 1992. Thrombosis and atherogenesis: molecular connections. Blood. 79:1897-1906.
9. Kreuzer, J., M.B. Lloyd, D. Bok, G.M. Fless, A.M. Scanu, A.J. Lusis, and M.E. Haberland. 1994. Lipoprotein(a) displays increased accumulation compared with low-density lipoprotein in the murine arterial wall. Chem. Phys. Lipids. 67:175-190.
10. Nielsen, L.B., S. Stender, M. Jauhiainen, and B.G. Nordestgaard. 1996. Preferential influx and decreased fractional loss of lipoprotein(a) in atherosclerotic compared with nonlesioned rabbit aorta. J. Clin. Invest. 98:563-571.
11. McLean, J.W., J.E. Tomlinson, W.J. Kuang, D.L. Eaton, E.Y. Chen, G.M. Fless, A.M. Scanu, and R.M. Lawn. 1987. cDNA sequence of a human apolipoprotein(a) is homologous to plasminogen. Nature (Lond.). 330:132-137.
12. Hajjar, K.A., D. Gavish, J.L. Breslow, and R.L. Nachman. 1989. Lipoprotein(a) modulation of the endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature (Lond.). 339:303-305.
13. Harpel, P.C., B.R. Gordon, and T.S. Parker. 1989. Plasmin catalyzes binding of lipoprotein(a) to immobilized fibrinogen and fibrin. Proc. Natl. Acad. Sci. USA. 86:3847-3851.
14. Miles, L.A., G.M. Fless, E.G. Levin, A.M. Scanu, and E.F. Plow. 1989. A potential basis for the thrombotic risk associated with lipoprotein(a). Nature (Lond.). 339:301-303.
15. Lawn, R.M., D.P. Wade, R.E. Hammer, G. Chiesa, J.G. Verstuyft, and E.M. Rubin. 1992. Atherogenesis in transgenic mice expressing human apolipoprotein (a). Nature (Lond.). 360:670-672.
16. Grainger, D.J., P.R. Kemp, A.C. Liu, R.M. Lawn, and J.C. Metcalfe. 1994. Activation of transforming growth factor β is inhibited in transgenic apolipoprotein(a) mice. Nature (Lond.). 370:460-462.
17. Lawn, R.M., A.D. Pearle, L.L. Kunz, E.M. Rubin, J. Reckless, J.C. Metcalfe, and D.J. Grainger. 1996. Feedback mechanism of focal vascular lesion formation in transgenic apolipoprotein(a) mice. J. Biol. Chem. 271:31367-31371.
18. Palabrica, T.M., A.C. Liu, M.J. Aronovitz, B. Furie, R.M. Lawn, and B.C. Furie. 1995. Antifibrinolytic activity of apolipoprotein(a) in vivo: human apolipoprotein(a) transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysis. Nat. Med. 1:256-259.
19. Mulichak, A.M., A. Tulinsky, and K.G. Ravichandran. 1991. Crystal and molecular structure of human plasminogen kringle 4 refined al 1.9 Å resolution. Biochemistry. 30:10576-10588.
20. Scanu, A.M., D. Pfaffinger, J.C. Lee, and J. Hinman. 1994. A single point mutation (trp72 - arg) in human apo(a) associated with a lysine binding defect in Lp(a). Biochim. Biophys. Acta. 1227:41-45.
21. Tomlinson, J.E., J.W. McLean, and R.M. Lawn. 1989. Rhesus monkey apolipoprotein(a). J. Biol. Chem. 264:5957-5965.
22. Scanu, A.M., L.A. Miles, G.M. Fless, D. Pfaffinger, J. Eisenbart, E. Jackson, J.L. Hoover-Plow, T. Brunck, and E.F. Plow. 1993. Rhesus monkey Lp(a) binds to lysine sepharose and U937 monocytoid cells less efficiently than human Lp(a). J. Clin. Invest. 91:283-291.
23. Klezovitch, O., C. Edelstein, and A.M. Scanu. 1996. Evidence that the fibrinogen binding domain of apo(a) is outside the lysine binding site of kringle IV-10. J. Clin. Invest. 98:185-191.
24. Guevara, J.J., A.Y. Jan, R. Knapp, A. Tulinsky, and J.D. Morrisett. 1993. Comparison of ligand-binding sites of modeled apo(a) kringle-like sequences in human lipoprotein(a). Arterioscler. Thromh. 13:758-770.
25. Ernst, A., M. Helmhold, C. Brunner, P. Petho-Schramm, V.W. Armstrong, and H.J. Muller. 1994. Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32-36 of human apolipoprotein(a). J. Biol. Chem. 270:6227-6234.
26. Frank, S., S. Durovi, and G.M. Kostner. 1994. Structural requirements of apo(a) for the lipopoprotein-a assembly. Biochem. J. 304:27-30.
27. Huby, T., W. Schroder, C. Doucet, J. Chapman, and J. Thillet. 1995. Characterization of the N-terminal and C-terminal domains of human apolipoprotein(a): relevance to fibrin binding. Biochemistry. 34:7385-7393.
28. Gabel, B.R., L.F. May, S.M. Marcovina, and M.L. Koschinsky. 1996. Lipoprotein(a) assembly: quantitative assessment of the role of apo(a) kringle IV types 2-10 in particle formation. Arterioscler. Thromb. Vasc. Biol. 16:1559-1567.
29. Trieu, V., and W.J. McConathy. 1995. A two-step model for lipoprotein(a) formation. J. Biol. Chem. 270:15471-15474.
30. Bett, A.J., W. Haddara, L. Prevec, and F.L. Graham. 1994. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. USA. 91:8802-8806.
31. Hughes, S.D., D. Rouy, N. Navaratnam, J. Scott, and E.M. Rubin. 1996. Gene transfer of cytidine deaminase p27 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits. Hum. Gene Ther. 7:39-49.
32. Callow, M.J., L.J. Stoltzfus, R.M. Lawn, and E.M. Rubin. 1994. Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice. Proc. Natl. Acad Sci. USA. 91:2130-2136.
33. Callow, M.J., J. Verstuyft, R. Tangirala, W. Palinski, and E.M. Rubin. 1995. Atherogenesis in transgenic mice with human apolipoprotein(a). apolipoprotein B, and lipoprotein(a). J. Clin. Invest. 96:1636-1646.
34. Mosedale, D.E., J.C. Metcalfe, and D.J. Grainger. 1996. Optimization of immunofluorescence methods by quantitative image analysis. J. Histochem, Cytochem. 44:1043-1050.
35. Hoover-Plow, J.L., N. Boonmark, P. Skocir, R. Lawn, and E.F. Plow. 1996. A quantitative immunoassay for the lysine-bindmg function of lipoprotein(a). Arterioscler. Thromb. 16:656-664.
36. Boonmark, N.W., X.J. Lou, Z.J. Yang, K. Schwartz, J.-L. Zhang, E.M. Rubin, and R.M. Lawn. 1997. Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice. J. Clin. Invest. 100:558-564.